Profile data is unavailable for this security.
About the company
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The Company's technology can also be applied to other mammalian species.
- Revenue in USD (TTM)1.38m
- Net income in USD-7.51m
- Incorporated2015
- Employees25.00
- LocationSenestech Inc23460 N. 19th Ave, Suite 110PHOENIX 85027United StatesUSA
- Phone+1 (928) 779-4143
- Fax+1 (302) 636-5454
- Websitehttps://senestech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cyclacel Pharmaceuticals Inc | 449.00k | -19.85m | 2.36m | 12.00 | -- | -- | -- | 5.25 | -21.99 | -21.99 | 0.4636 | -1.67 | 0.0318 | -- | 0.1204 | -- | -139.57 | -57.58 | -314.22 | -69.81 | -- | -- | -4,386.86 | -18,789.29 | -- | -128.51 | -- | -- | -- | 22.87 | -6.34 | -- | -31.23 | -- |
| Eloxx Pharmaceuticals Inc | 0.00 | -20.48m | 2.36m | 18.00 | -- | -- | -- | -- | -9.06 | -9.06 | 0.00 | -6.53 | 0.00 | -- | -- | 0.00 | -124.43 | -115.27 | -- | -155.33 | -- | -- | -- | -- | -- | -16.69 | -- | -- | -- | -- | 45.95 | -- | -22.56 | -- |
| Aclarion Inc | 60.05k | -6.13m | 2.38m | 6.00 | -- | 0.83 | -- | 39.71 | -7.41 | -7.41 | 0.0341 | 0.3502 | 0.0215 | -- | 3.50 | 10,008.33 | -219.26 | -- | -337.53 | -- | -29.49 | -- | -10,203.20 | -- | -- | -- | 0.211 | -- | 24.75 | -- | 34.38 | -- | -- | -- |
| Regen BioPharma Inc | 236.58k | -851.69k | 2.47m | 1.00 | -- | -- | -- | 10.44 | -0.2271 | -0.2271 | 0.0633 | -1.26 | 0.8644 | -- | 3.98 | 236,580.00 | -327.54 | -104.36 | -- | -- | -- | -- | -378.93 | -275.00 | -- | -1.32 | -- | -- | 0.4416 | 18.79 | -58.11 | -- | -- | -- |
| Cingulate Inc | 0.00 | -22.50m | 2.48m | 13.00 | -- | 0.5252 | -- | -- | -22.66 | -22.66 | 0.00 | 0.6419 | 0.00 | -- | -- | 0.00 | -355.56 | -- | -1,198.96 | -- | -- | -- | -- | -- | -- | -33.88 | 0.0054 | -- | -- | -- | -33.14 | -- | -- | -- |
| Qrons Inc | 0.00 | -763.52k | 2.53m | 2.00 | -- | -- | -- | -- | -0.0562 | -0.0562 | 0.00 | -0.1078 | 0.00 | -- | -- | 0.00 | -18,782.78 | -1,513.45 | -- | -- | -- | -- | -- | -- | -- | -19.02 | -- | -- | -- | -- | -7.61 | -- | -- | -- |
| SenesTech Inc | 1.38m | -7.51m | 2.55m | 25.00 | -- | 0.5524 | -- | 1.85 | -15.21 | -15.21 | 0.7189 | 0.8961 | 0.2718 | 0.939 | 13.29 | 55,000.00 | -148.36 | -118.53 | -178.99 | -140.61 | 42.33 | 39.40 | -545.82 | -1,357.86 | 5.69 | -- | 0.0378 | -- | 17.08 | 32.06 | 20.47 | -- | -9.02 | -- |
| Exicure Inc | 500.00k | -13.34m | 2.61m | 6.00 | -- | 1.18 | -- | 5.21 | -1.56 | -1.56 | 0.0582 | 0.2551 | 0.0289 | -- | -- | 83,333.34 | -76.97 | -41.52 | -91.14 | -55.78 | -- | -- | -2,667.20 | -290.95 | -- | -- | 0.00 | -- | -100.00 | -- | -555.07 | -- | -- | -- |
| Entero Therapeutics Inc | 0.00 | -6.44m | 2.65m | 15.00 | -- | 0.1339 | -- | -- | -51.90 | -51.90 | 0.00 | 38.45 | 0.00 | -- | -- | 0.00 | -12.74 | -295.92 | -14.01 | -1,599.51 | -- | -- | -- | -- | -- | -265.69 | 0.0802 | -- | -- | -- | -7.55 | -- | -- | -- |
| Tharimmune Inc | 0.00 | -8.89m | 2.67m | 2.00 | -- | 0.3791 | -- | -- | -111.65 | -111.65 | 0.00 | 8.97 | 0.00 | -- | -- | 0.00 | -130.60 | -- | -173.40 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.98 | -- | -- | -- |
| Qualigen Therapeutics Inc | 0.00 | -12.48m | 2.69m | 4.00 | -- | -- | -- | -- | -2.46 | -2.64 | 0.00 | -0.3923 | 0.00 | -- | -- | 0.00 | -118.15 | -- | -364.72 | -- | 21.30 | -- | -- | -- | -- | -7.41 | -- | -- | -- | -- | 10.22 | -- | -- | -- |
| Tron Pharmaceuticals Inc | 1.01m | -549.47k | 2.75m | 50.00 | -- | -- | -- | 2.73 | -0.0034 | -0.0034 | 0.0062 | -0.0508 | -- | -- | -- | 20,191.00 | -- | -- | -- | -- | 60.28 | -- | -110.51 | -- | 0.0417 | -433.32 | -- | -- | 0.3272 | -- | -39.70 | -- | -- | -- |
| Revelation Biosciences Inc | 0.00 | -8.96m | 2.82m | 9.00 | -- | 0.2982 | -- | -- | -32.09 | -32.09 | 0.00 | 5.80 | 0.00 | -- | -- | 0.00 | -54.61 | -- | -91.95 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 98.89 | -- | -- | -- |
| Bio Path Holdings Inc | 0.00 | -13.96m | 2.83m | 10.00 | -- | -- | -- | -- | -27.39 | -27.39 | 0.00 | -3.48 | 0.00 | -- | -- | 0.00 | -216.97 | -70.80 | -390.65 | -76.87 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -15.94 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| McAdam LLCas of 31 Mar 2024 | 64.35k | 1.25% |
| Citadel Securities LLCas of 31 Mar 2024 | 52.54k | 1.02% |
| G1 Execution Services LLCas of 31 Mar 2024 | 18.82k | 0.37% |
| Virtu Americas LLCas of 31 Mar 2024 | 16.61k | 0.32% |
| HRT Financial LLCas of 31 Mar 2024 | 10.20k | 0.20% |
| Sabby Management LLCas of 31 Mar 2024 | 6.26k | 0.12% |
| Tower Research Capital LLCas of 31 Mar 2024 | 6.25k | 0.12% |
| UBS Securities LLCas of 31 Mar 2024 | 428.00 | 0.01% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 7.00 | 0.00% |
| Old Point Trust & Financial Services, NA (Invt Mgmt)as of 31 Mar 2024 | 4.00 | 0.00% |
